chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a pharmacist via call center representative and described the occurrence of hives in a female patient who received FLULAVAL QUADRIVALENT. On an unknown date, the patient received FLULAVAL QUADRIVALENT at an unknown dose. On an unknown date, 1 hr after receiving FLULAVAL QUADRIVALENT, the patient experienced hives and pruritus. On an unknown date, the outcome of the hives and pruritus were recovered/resolved. The reporter considered the hives and pruritus to be probably related to FLULAVAL QUADRIVALENT. Additional details were provided as follows: The age at vaccination was not reported. In 2017, the patient received FLULAVAL QUADRIVALENT and experienced hives and pruritus. The reporter was asking if patient could receive HAVRIX despite this reaction to FLULAVAL. She did not have any product specific information or patient information (or much information about the adverse event). She stated that someone was filling out a VAERS.
Fevers; Chills; Felt like I was going to faint; Arm was hurting; Felt super bad; Felt super hot then very cold; Felt like I had to vomit but I didn't; Pale; When I tried to move my arm I couldn't move it at all it was like it completely fell asleep; Fingers twisted; Smelled alcohol; Back hurt; Head hurt/light headaches; This is a spontaneous report from a contactable consumer(patient) reported for herself. A 30-years-old female patient received second dose bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 06May2021 (Batch/Lot Number: EW0172) at 0.3 ml single for COVID-19 immunization.  The patient had no known allergies and other medical history. The patient did not have COVID-19 prior vaccination. The patient was not pregnant. No other medications the patient received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose bnt162b2 (BNT162B2), administered in Arm Left on 15Apr2021 04:00 pm (Lot Number: EW0153) for COVID-19 immunization. The next day after she got the vaccine, when she woke up her arm was hurting and then out of nowhere she felt super bad that she had to sit on the floor because she felt like she was going to faint. Then she felt superhot then very cold and she felt like she had to vomit but she didn't, her mom said she was pale and then when she tried to move her arm she couldn't move it at all it was like it completely fell asleep and her fingers twisted. she smelled alcohol and she started feeling better, all this happened in a matter of 10-15 mins. Then she spent the whole day in bed with fevers and chills every once in a while. The next couple of days her back hurt and her head hurt. she still get light headaches and her back hurts sometimes. Event onset date was 07May2021 09:00. The patient did not receive treatment for the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The patient come of the events was recovering
Pneumonia immunization yesterday and today upper left arm is swollen with fine-grained red rash.
Service member received anthrax and typhoid. 40 minutes later developed rash on neck, chest, and upper back. She denies itching, tachycardia, SOB. She is walking around, A/Ox3. She reports feeling dizzy and anxious. Sent to local urgent care for evaluation.
not feeling well; weak; in pain; This is a spontaneous report from a Pfizer sponsored program. A non-contactable consumer reported for a female patient of an unspecified age received BNT162B2 (Pfizer COVID-19 Vaccine, Solution for injection), dose 1 via an unspecified route of administration on 18May2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medication was not reported. When caller wanted to reschedule the 2nd dose of vaccine, the patient experienced not feeling well, weak and pain on unspecified date in May2021. The clinical outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recv vax; high pitched cry for 36 hr; no tx; no change w/ apap;
pt. recvd. 2 doses of vax w/in 6 month period.
INJECTION SITE PAIN THAT DAY, BUT NEXT DAY HAS BEEN INCREASING INABILITY TO LIFE ARM WITHOUT PAIN, OR WITHOUT ASSISTANCE. IS NOT ABLE TO LIFT ARM VERY FAR AT ALL WITHOUT ASSISTANCE, AND AFTER A CERTAIN LEVEL OF HEIGHT HAS  INCREASING PAIN.
This spontaneous report was received from a physician via company representative refers to a 16 year old male patient. The patient's medical history and concomitant medications were not reported. On 08-JUN-2016, the patient was vaccinated with GARDASIL (strength, dose, route were unknown) lot # M003659 and expiry date 20-SEP-2017 for immunization at physician office. On 08-JUN-2016, on the same day, when the patient was leaving the office, he fainted in the elevator (syncope). The outcome of syncope was reported as recovered. The causality assessment was not provided.
patient who is having a delayed reaction from the first shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE REACTION (patient who is having a delayed reaction from the first shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (patient who is having a delayed reaction from the first shot). At the time of the report, VACCINATION SITE REACTION (patient who is having a delayed reaction from the first shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant  information was  provided. No Treatment information was  provided.
chest issues; Nervous; overweight; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 16-year-old male patient received BNT162b2 (BNT162B2), on 31Jul2022 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHEST DISCOMFORT (non-serious), outcome "recovering", described as "chest issues"; NERVOUSNESS (non-serious), outcome "unknown", described as "Nervous"; OVERWEIGHT (non-serious), outcome "unknown".  Additional information: Patient was really scared that will get severely sick and die or go to hospital. Patient was scared gonna be hospitalized because was overweight and know being overweight is a big issue when having covid. What are my chances of being hospitalized? Very nervous also since I had a bad reaction to the vaccine will that make me more vulnerable with covid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Runny nose; Sore throat; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose) and OROPHARYNGEAL PAIN (Sore throat) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced RHINORRHOEA (Runny nose) and OROPHARYNGEAL PAIN (Sore throat). At the time of the report, RHINORRHOEA (Runny nose) and OROPHARYNGEAL PAIN (Sore throat) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided. No treatment information mentioned.  Patient experienced a runny nose and sore throat.  The reporters causality for the events with Humira was no reasonable possibility.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
2/3/06 received Td.  Noticed joint pain R arm that PM.  Pain worse when lying on R arm.  Complained L leg pain 4 days later (2/7/06).
I received my vaccination on Friday, February 19th.  On Sunday, February 21st, my tongue felt like I had scalded it with a hot drink, and my taste buds were very sensitive.  My tongue also felt thick and there were bumps on the sides of it.  On Tuesday, February 23rd, I noticed I couldn't whistle, and I couldn't spit correctly when I brushed my teeth.  On Wednesday, February 24th, I noticed my right eyebrow was lower than my left, and my mouth was drooping on the right side.  I couldn't put my lips together to put my chapstick on,  and my smile was very crooked.  Additionally I felt my eyelid twitching and the right side of my face felt very strange in general.  So I contacted the nurse who administered the vaccine.  She said that Bell's Palsey could be symptom from the vaccine, and that I should contact my physician.  So I called Dr. office and they did a virtual appointment with me on Wednesday afternoon.  He immediately told me I have Bell's Palsey as a result of the vaccine and sent in some prescriptions for me to take.  They are Toradol Oral, Prednisone, and Erythromycin Ointment for my eye because it won't close all the way, and it doesn't blink properly.
8/2/07 eyes watery, vomited x1, warm to touch within hour after shot. 8/3/07 arm itchy; swollen, red. 8/4/07 swelling 1/2" above elbow to shoulder, outer aspect of arm and under arm red and swollen also. Mom called insurance. Nurse advised she be seen. Mom took to clinic (an urgent care facility). Mom advised to give Tylenol, Benadryl, and see PCP in 3-5 day. Mom brought child into PCP (our office) on 8/9/07 for follow-up. At that time reaction had resolved.
Within the first 10 mins, I had chest tightness but I did not need my inhaler. After 5 hours, I started to develop numbness, weakness, heaviness and tingling in my arms and legs. I also felt dizzy when standing up. I had poor coordination when walking and in order keep my balance, I had to walk very slow. Bending down or getting up too quickly would cause me to lose my balance or feel very dizzy. Objects "feel" heavy and it takes much effort to lift anything over 10 lbs. This has continued since 4/16 with gradual improvement. As of today, I still have numbness and tingling in my arms. Fine motor tasks are very difficult and take lots of effort. Items over 10 lbs still require much effort to lift. I still get dizzy when moving fast or bending down or standing up from a sitting position fast. Walking is still an issue as I need to walk slowly to keep my balance. Walking up or down stairs or inclined surface is somewhat difficult for me to keep my balance.
Roughly 7 hours after injection, began experiencing severe chest pain, followed shortly by fever ranged (101-104 during duration), severe back pain, much increased urination throughout the night.  Sleep was impossible.  By early morning (roughly 6 am) my wife hard to help me to bathroom due to lack if energy and balance.  At 8:30 AM I called my family physician when their office opened, they directed me to the hospital.  By then, I was so sick my wife had to drive me.  I don't remember the drove in and only vaguely recall By memory the events at the hospital.  According to my wife, I was given an EKG, chest xray, and urine test.  After, they injected me with a steroid, benadryl, and an anti nausea medication.  After roughly 4-5 hours, I began to feel slightly better.  At the time of me writing this, I am still not fully recovered.  I am still experiencing lack if energy, nausea, and some schest pain.  I believe it is also worth noting that I had a similar, though less severe and untreated event with the second pfizer vaccine (of the first 2 original shots).  in that instance, my fever also went to 104, though I did not have the chest pains or frequent urination.
Patient had acute hypoxic respiratory failure and patchy bilateral pneumonia with negative Covid PCR test and other negative viral and bacterial studies.  She ended up hospitalized in respiratory failure and ultimately survived after 5 days in the hospital.
joint pain; fatigue; low fever; diarrhea; slight runny nose; muscle pain; This is a Spontaneous report from a Contactable Pharmacist. This 62-year-old female Pharmacist reported for herself that:  A 62-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9267), via an unspecified route of administration, administered in Arm Left on 22Feb2021 13:15 (at the age of 62 years old) as SINGLE DOSE for covid-19 immunisation.  Medical history included myofascial pain (Myofascial pain syndrome) from an unknown date and unknown if ongoing, shoulder impingement (rotator cuff syndrome) from an unknown date and unknown if ongoing, atrial fibrillation from an unknown date and unknown if ongoing , spinal fusion surgery from an unknown date and unknown if ongoing. Concomitant medication(s) included Multaq (dronedarone hydrochloride) taken for an unspecified indication, start and stop date were not reported; Eliquis (Apixaban) taken for an unspecified indication, start and stop date were not reported; Protonix (Omeprazole) taken for an unspecified indication, start and stop date were not reported; Digoxin (Digoxin) taken for an unspecified indication, start and stop date were not reported; Biotin (Biotin) taken for an unspecified indication, start and stop date were not reported.  It was reported that no other vaccine administered in four weeks. Covid prior to vaccination was no. Covid tested post vaccination was yes. Patient had no known allergies. The patient experienced joint pain, fatigue, low fever, diarrhea, slight runny nose, muscle pain on 23Feb2021 23:00. The patient underwent lab tests and procedures which included Nasal Swab (sars-cov-2 antibody test negative): negative on 10Mar2021. Therapeutic measure were taken as unknown as a result of event. The outcome of events was not recovered.   No follow-up attempts are possible. No further information is expected.
Onset of severe pain, subscapular, level 7 of 10 24/7; pain still present with no decrease in intensity. Family physician prescribed steroid pak on 2-5-10, completed 2-10-10 with no beneficial effect.
Face knees feet and hands feel frozen; Face knees feet and hands were throbbing/ Face knees feet and hands were aching; Leg was throbbing; No appetite; Felt sick all the time; Sick to the stomach; Diarrhea; Lost 14 lbs; This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT DECREASED (Lost 14 lbs), FROSTBITE (Face knees feet and hands feel frozen), PAIN IN EXTREMITY (Face knees feet and hands were throbbing/ Face knees feet and hands were aching), PAIN IN EXTREMITY (Leg was throbbing) and DECREASED APPETITE (No appetite) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD and Diabetic.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced WEIGHT DECREASED (Lost 14 lbs). On an unknown date, the patient experienced FROSTBITE (Face knees feet and hands feel frozen), PAIN IN EXTREMITY (Face knees feet and hands were throbbing/ Face knees feet and hands were aching), PAIN IN EXTREMITY (Leg was throbbing), DECREASED APPETITE (No appetite), ILLNESS (Felt sick all the time), ABDOMINAL DISCOMFORT (Sick to the stomach) and DIARRHOEA (Diarrhea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, WEIGHT DECREASED (Lost 14 lbs), FROSTBITE (Face knees feet and hands feel frozen), PAIN IN EXTREMITY (Face knees feet and hands were throbbing/ Face knees feet and hands were aching), PAIN IN EXTREMITY (Leg was throbbing), DECREASED APPETITE (No appetite), ILLNESS (Felt sick all the time), ABDOMINAL DISCOMFORT (Sick to the stomach) and DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included diabetic medication. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
No additional AE; Nurse reported PROQUAD was administered after TE; see TE case 02487539. See full details below. No additional AE/no PQCs.    ?    Names of vaccines involved PROQUAD X009129 9/24/2024        ?    Temperature 8.1°F        ?    Time frame 3 hours; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported.   On 28-SEP-2023, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # X009129, expiration date: 24-SEP-2024, therapy type stablished as rHA) (strength, route of administration, anatomical location not provided) as prophylaxis; which underwent a temperature excursion at 8.1 Fahrenheit (F) during 3 hours. No additional adverse event was reported.
19 mo old child received DTP/prohibit immunization  18JAN90. At 10PM woke up, at 2AM had grand mal seizure lasting 1 min. Temp 107 hospitalized; normal work up; neurologist consult pending; no prior reaction to 3 prior DTP's.
Around 30 hours post injection patient experienced left arm and left side of face total numbness and  paralyses. These symptoms moved to right side of face and down the left side of body; left upper back and left chest. Patient said it felt like she was experiencing what is described as Bell's Palsy type symptoms. These symptoms lasted until 8/30/21 then they started fading.
Pt came in for her first dose of the pfizer vaccine. At vaccination,showed that the pt received a first dose of moderna on 7/27/21. When asked, the pt stated that she had not received any  covid vaccine. Pt was informed that having mixed covid vaccines is not approved by CDC, and her immunization record would not be accurate, resulting in her not being able to receive further doses (given that there are two records of separate vaccines present on her ). Pt reiterated not having taken any covid vaccine. AP Nurse Hotline was called to ask how to proceed at 2:19 PM. After calling the hotline, we reviewed the latest AP update from 7/28/21 that stated to escalate the issue if a pt discloses having received another covid vaccine. Due to this, we proceeded with the Pfizer vaccine at approximately 3:30 PM and noted in pts EMR record (pt denies having received another covid vaccine) as we were previously instructed to do so, being that the EMR CIR is not 100% accurate. At 3:46 PM the hotline called back and informed that reflected that there was a Moderna dose from 7/27/21 and a Pfizer dose from 8/1/21. Pt was still in observation, and when questioned again, she continued to attest to not receiving the moderna vaccine. Pt denied having received any Covid vaccine throughout the entire process. Pt left at 3:55 PM.
From initial information received on 09MAY2003 from a registered nurse, regarding an adverse event occurring in the US, it was reported that a 29 year old female patient received her second dose of IMOVAX RABIES, lot number U0961, in the right deltoid on 24APR2003. After the vaccination, the patient experienced pain in her wrist so severe that she had an x-ray taken to determine if it was broken, she also had difficulty lifting her arms. The patient was seen by a physician on an unspecified date. Reportedly, the patient did not recover from these events. The patient had received her first dose of IMOVAX rabies, lot number U0595-2, in the left deltoid on 17APR2003. After this vaccination, the patient experienced pain radiating to her neck and into here back as well as feeling nausea. The patient had allergies to Aspirin, codeine, Sulfa and vicoden and was taking Flagyl at the time of vaccination. The reporter of this case is the same reporter for case 2003-01001
Dose administered past the expiration date of a  Moderna Covid-19 vaccine as a Booster dose; Received 0.5 ml as a booster dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered past the expiration date of a  Moderna Covid-19 vaccine as a Booster dose) and ACCIDENTAL OVERDOSE (Received 0.5 ml as a booster dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033h21A and 035C21A) for COVID-19 vaccination.     Concomitant products included ESTROGENS CONJUGATED (PREMARIN), SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]), ACETYLSALICYLIC ACID (ASPIRIN ANALGESIC) and COLECALCIFEROL (VITAMIN D3) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 29-Mar-2022, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 29-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered past the expiration date of a  Moderna Covid-19 vaccine as a Booster dose) and ACCIDENTAL OVERDOSE (Received 0.5 ml as a booster dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered past the expiration date of a  Moderna Covid-19 vaccine as a Booster dose) and ACCIDENTAL OVERDOSE (Received 0.5 ml as a booster dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient concomitant medication included Hydra 500 mg The reporter confirmed that patient received third and booster dose on her deltoid muscles. Reporter did not know if the patient had experiencing any symptoms. Date the vial initially stored in refrigerator: 7-Mar-2022 The vial did not under go any temperature excursions. No treatment information provided.
sinus infection; Bad headache behind her right ear; fatigue; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinus infection), HEADACHE (Bad headache behind her right ear), FATIGUE (fatigue) and MYALGIA (muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced SINUSITIS (sinus infection), HEADACHE (Bad headache behind her right ear), FATIGUE (fatigue) and MYALGIA (muscle pain). At the time of the report, SINUSITIS (sinus infection), HEADACHE (Bad headache behind her right ear), FATIGUE (fatigue) and MYALGIA (muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.  "Follow-up received on 13 May 2021 included no new information.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow up received included reporters mail id.